Log In
BCIQ
Print this Print this
 

CD52

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD52

BCIQ
Print ChartPrint this
1 0 0 1 0 1
Phases of DevelopmentPhase IVMarketed
Autoimmune

0

1

Cancer

0

1

Transplant

1

0




 Products Targeting CD52
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$26,800.0M

$20,100.0M

$3,800.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today